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Background: Lacking any squamous epithelium, thyroid gland with primary squamous cell carcinoma (PSCC)
proves to be an etiopathophysiological quandary. Two major theories do exist, though few cases have been
documented to support either. We present a case that supports the “metaplasia” theory, which serves to enhance
our understanding of a disease that carries with it a very poor prognosis.
Case presentation: We present a case of an extremely advanced, primary squamous cell carcinoma of the thyroid
with distant metastases in a thirty-six year-old male. Dying of airway compromise seventeen days following his
admission, this is the shortest median survival of all documented cases.
Conclusion: In addition to being the most abbreviated time period between presentation and death of all
documented thyroid primary squamous cell carcinomas, we share the fifth case of thyroid PSCC in the setting of
lymphocytic thyroiditis. This case should build awareness of the aggressivity of the disease and the lack of
established diagnostic criteria.Background
Comprising less than 1% of all thyroid cancers, primary
squamous cell carcinoma (PSCC) of the thyroid is ex-
ceedingly rare. It has a median age of presentation falling
in the fifth and sixth decades of life [1,2]. A foreshor-
tened history of an enlarging mass, pain, and hoarseness
are often associated with presentation [3]. Diagnosis can
often be challenging since squamous metaplasia is evi-
dent in other primary and metastatic thyroid neoplasms
[4,5]. Moreover, the possibility of direct extension from
adjacent SCC of the larynx contributes to the diagnostic
difficulty [5]. The diagnosis of PSCC should include
deduction via clinical, endoscopic, radiographic, and
histologic inference [2,4,5]. Irrespective of multimodality
treatments including surgery, radiotherapy, and chemo-
therapy, PSCC carries a poor prognosis. Median survival
rates as short as three months have been reported [3,4].
We describe a case of an extremely advanced, primary
squamous cell carcinoma of the thyroid with distant me-
tastases in a thirty-six year-old male. With a one-month
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following his admission. Furthermore, given a previous
diagnosis of lymphocytic thyroiditis prior to presenta-
tion, we present one of the few documented cases of
PSCC in the setting of lymphocytic thyroiditis.Case presentation
A thirty-six year-old male presented to the emergency
department with a one-month history of increasing left
neck mass accompanied by pain, severe shortness of
breath, and eight kilograms of unintentional weight loss.
He had spent several months in Ethiopia prior to pre-
senting to our centre, where the working diagnosis for
his neck mass was lymphocytic thyroiditis, based on sev-
eral FNA biopsies. As a result, propylthiouracil (PTU)
and propranolol were prescribed. His past medical, fam-
ily and social histories were all unremarkable for malig-
nant risk factors. Upon presentation, he was found to be
euthyroid (TSH = 0.42 mU/L, Free T3 = 4.3 pmol/L, and
Free T4 = 22.7 pmol/L). His thyroid indices prior to
starting PTU were unavailable and thus, we can only as-
sume that he was in a hyperthyroid state prior to admin-
istration of PTU.
CT scans revealed a mass arising from the thyroid
measuring 8 × 9 × 12 cm, which stretched from the hyoidThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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was situated just left of midline within level VI. Along
with invasion of the esophagus, left thyroid and aryten-
oid cartilages, the tumor completely effaced both the left
internal carotid and internal jugular vessels (Figure 1).
The trachea was significantly displaced to the right with
the narrowest luminal segment measuring 7 mm. In
addition to the extensive lymph node involvement from
level IA to the supraclavicular fossa, upper mediastinal
lymphadenopathy with innumerable pulmonary metasta-
ses up to 2.1 cm was noted. Following the biopsy and in
light of the imaging, the tumor was staged T4b, N1b,
M1 [6].
In order to secure this precarious airway, an awake in-
tubation in the operating room was successfully carried
out. This was followed by an open biopsy of the neck
mass. Endoscopy was not pursued given the significant
esophageal obstruction. After careful review by the
multidisciplinary Head and Neck Oncology team, it was
felt that based on the significant invasion of neighbouring
structures, the tumor was surgically unresectable. More-
over, a tracheostomy was considered unreasonable given
the impressive superimposition of the tumor on the tra-
chea. Chemotherapy and radiotherapy were considered
less desirable options since the patient was now requiring
aggressive ventilator and hemodynamic supports.
Given the few alternatives, a family meeting was held
and as per the patient and his family’s wishes, a trial of
extubation was attempted. It was agreed upon that it
would not be beneficial to the patient to reintubate,
should the airway deteriorate post extubation. Despite
his extubation to heliox and the use of epinephrine neb-
ulizers, he became increasingly stridulous and hypoxic.
As per his previous wishes, the patient was provided
comfort measures and he passed shortly after.Figure 1 Computer tomography (CT) of the neck revealing a
9 × 12 cm extensively infiltrative mass. * = trachea.Pathologic findings
The biopsy specimen measured 1.7 × 1.2 cm. The
hematoxylin and eosin (H&E) stained sections showed
invasive, moderately differentiated squamous cell carcin-
oma involving skeletal muscle (Figure 2A). The neoplas-
tic cells were disposed in sheets, nests and anastomosing
cords. They were predominantly polygonal, but a minor
spindle-shaped component was also present (Figure 2B).
These cells had abundant eosinophilic cytoplasm with
well-defined borders. Intercellular bridges were present
but keratin production was not detected. The neoplas-
tic nuclei were large, pleomorphic and contained ves-
icular chromatin and prominent nucleoli (Figure 2C).
Scattered mitotic figures were present but necrosis was
not evident.
By immunohistochemistry, the tumor cells were posi-
tive for cytokeratins 5/6, 7, 19 and p63 (Figure 3A–C).
Stains for cytokeratin 20, thyroglobulin, TTF1, synapto-
physin, chromogranin, calcitonin, CD5 and p16 were
negative (Figure 3D). Normal thyroid tissue or other
histologic types of thyroid carcinoma in the biopsy spe-
cimen were lacking.
Discussion
The diagnosis of thyroid PSCC is often achieved through
a combination of clinical, radiologic, and ultimately
histologic findings. Making the diagnosis can be challen-
ging and some authors would believe that PSCC does
not exist as an entity unto itself [2,4]. Clinically resem-
bling anaplastic thyroid cancer, PSCC is extremely ag-
gressive with median survival rates of less than six
months often due to airway obstruction causing death
[2,7,8]. With a one-month history of a neck mass
coupled with a seventeen-day span between our patient’s
presentation and death, we present the shortest median
survival of all documented cases [4,9]. This abbreviated
clinical course may be due to the absence of therapy,
though PSCC cases lacking intervention possessed lon-
ger median survival periods [3,4,9]. While an immuno-
compromised state can accelerate neoplastic growth, this
patient had a complete immune workup, and no defi-
ciencies were detected. Presenting symptoms can include
sudden onset of an enlarging mass, dysphagia, hoarse-
ness, and pain, which were noted in the case presented
[4,7]. Radiographically, PSCC often presents with ad-
vanced infiltration and effacement of neighbouring
structures, which was noted in our case, given the inva-
sion of the esophagus, displacement of the trachea and
proximity to neck vasculature.
To further delineate thyroid PSCC from other differ-
ential diagnoses such as carcinoma showing thymus-like
differentiation (CASTLE) and metastatic squamous cell,
immunochemistry can be useful [2]. CASTLE tumors
have been shown to exhibit CD5 expression, which our
Figure 2 H&E stains at 200X. (A) Carcinoma infiltrating skeletal muscle. (B) Squamous cell carcinoma with polygonal cells and spindle shaped
cells. (C) Under 400X magnification, polygonal cells with well-defined cytoplasmic borders, intercellular bridges and prominent pleomorphic
nuclei were evident. A mitotic figure at 1 o’clock position is seen.
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profiles of SCC often lack specificity, though CK7 and
19 have been shown to be positive in PSCC [2,6,9]. This
was the case in our histological findings. Diagnosis of
primary SCC was primarily supported by the histologic
morphology of the biopsy. Given a negative calcitonin,
medullary thyroid carcinoma diagnosis was also ex-
cluded [4,7]. As per Lam et al.’s findings, CK20 expres-
sion was negative, which refutes gastric, intestinal, or
urothelial squamous cell carcinomas, which could poten-
tially have metastasized to the thyroid [2,3,9]. Further-
more, in keeping with other thyroid PSCC cases in the
literature, a negative TTF-1 and thyroglobulin helps to
support the diagnosis of PSCC by excluding a cancer
arising from follicular thyroid cells [2,4,10]. With the
absence of radiographic evidence for a distant site of pri-
mary SCC, the supportive immunohistochemistry find-
ings, and the unique morphology at the cellular level, weFigure 3 Immunoperoxidase stains at 200X magnification. (A) Tumor
positive for cytokeratin 19. (C) Neoplastic nuclei positive for p63. (D) T-lympfelt this presentation was most representative of a PSCC
of the thyroid.
Interestingly, several weeks prior to presenting to our
Emergency Department, a FNA biopsy performed in
Ethiopia was suggestive of lymphocytic thyroiditis, which
brings to light the debate of thyroid PSCC etiopathology.
Two prominent concepts regarding the pathophysiology
of PSCC exist including the “embryonic rest cell” and
“metaplasia” theories [2,5,8,10,11]. Squamous cell deriv-
ation from remnants of the thyroglossal duct, the
ultimobranchial body, and thymic epithelium is the basis
of the “embryonic rest cell” theory [4,8,12]. The more
accepted “metaplasia” theory, however, postulates the
source of squamous cells to be from follicular, papillary
or anaplastic cells [5,10,11]. The most common process
of squamous metaplasia, Hashimoto’s Thyroiditis, has
been associated with PSCC of the thyroid in four docu-
mented cases [1,10,11]. Given the patient’s previouscells positive for high molecular weight cytokeratin 5/6. (B) Tumor cells
hocytes positive for CD5 labelling.
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graphically and histologically, this case likely aligns with
previous cases of PSCC in the setting of lymphocytic
thyroiditis, which makes this the fifth noted case in
literature.
Unfortunately, there is no established treatment mo-
dality or combinations thereof to address PSCC, pri-
marily due to the rarity of the presentation [2,4,12].
The tumor presented in this case was deemed unresect-
able due to invasion of the mass into neurovascular
structures. Supportive measures were undertaken in-
cluding a PEG tube, while chemoradiation was felt to
not be feasible.Conclusions
We present the shortest documented median survival of
primary squamous cell carcinoma of the thyroid gland in
a thirty-six year-old male. The tumor’s morphology and
immunoprofile were considered consistent with a pri-
mary neoplasm of the thyroid gland, arising in the back-
ground of lymphocytic thyroiditis. This case should
build awareness of the aggressivity of the disease and the
lack of established treatment options. Despite the rarity
of this disease process, further discussion regarding diag-
nostic criteria discussion should be pursued.Consent
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